Brief: Piramal Pharma Limited Announces Consolidated Results For Q2 And H1 FY2024
Oct 28 (Reuters) - Piramal Pharma Ltd PIRM.NS :
* Q2 FY24 REVENUE FROM OPERATION INR 1,911 CRORES, UP 11%
* LIMITED ANNOUNCES CONSOLIDATED RESULTS FOR Q2 AND H1
FY2024
Source text for Eikon: ID:nCNW7b99Ra
Further company coverage: PIRM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma (Mumbai) Says Commercial Arrangement With Bayer Pharmaceuticals To Expire On December 31, 2026
Brief: Piramal Pharma (Mumbai) Says Tax Authority Confirms Demand Of 40.6 Million Rupees And Imposes Equivalent Penalty
India's Piramal Pharma falls after US FDA observations at UK facility
Brief: Piramal Pharma Says US FDA Issues Form-483 With 7 Observations To Morpeth UK Facility
Brief: Piramal Pharma Approves Exercise Of Call Option For Acquisition Of Additional 41% Equity In Yapan Bio